Trump tariffs live updates: Trump signals drug tariffs may come by Aug. 1, announces deal with Indonesia

President Trump's administration is aggressively implementing protectionist trade policies, exemplified by a new 19% tariff deal with the Philippines and escalating tensions with major partners like the EU and India ahead of an August 1 deadline for widespread duties. This tariff-heavy approach is generating significant market uncertainty and negatively impacting corporate earnings and forecasts across diverse sectors, including aerospace (RTX), automotive (GM, Stellantis), and consumer goods, while prompting retaliatory preparations from the EU and forcing global supply chain reconfigurations. While some domestic industries, such as steel, report positive impacts, the policy is broadly disrupting international trade and contributing to consumer price increases.

Analysis

The US administration's aggressive protectionist trade policy is creating significant market disruption and a clear divergence in corporate performance ahead of a critical August 1 tariff deadline. The negative impact is material and immediate for multinational manufacturers, with General Motors (GM) reporting a 32% drop in core profit, attributing a $1.1 billion hit directly to tariffs, and aerospace firm RTX cutting its 2025 profit forecast. Similarly, Stellantis (STLA) has warned of a potential €2.3 billion loss, citing tariffs as a key factor. Conversely, domestically-focused producers like steelmaker Cleveland-Cliffs (CLF) are experiencing a windfall, with its CEO praising the policy's "positive impact" and the company's stock soaring 11% on record shipments. Corporates are actively responding to this new reality; AstraZeneca (AZN) announced a $50 billion investment in US manufacturing to de-risk its supply chain, while Coca-Cola (KO) expressed caution despite believing it can manage the effects. The policy's broader economic consequences include potential consumer price hikes of 20-25% for goods like orange juice, supply chain re-routing by China, and escalating geopolitical tensions, with the EU preparing retaliatory measures as negotiations with the US remain on a knife's edge.

Key Decisions for Investors

• Investors should re-evaluate exposure to multinational automotive and aerospace companies like GM, Stellantis, and RTX, which have demonstrated significant profit erosion and negative forecast revisions directly attributable to tariff costs.
• Consider positions in domestic-focused industrial producers, such as US steelmaker Cleveland-Cliffs, that benefit directly from import protectionism and have shown strong performance amid the trade disputes.
• Monitor companies making significant domestic manufacturing investments, like AstraZeneca's $50 billion commitment, as these actions could signal long-term resilience and insulation from supply chain and tariff volatility.
• Prepare for heightened market volatility leading up to the August 1 tariff deadline, as negotiations with the EU remain precarious and official statements are conflicting, suggesting a high probability of a binary, market-moving outcome.